Safety Study of allogenic hiPSC-retinas in Retinitis Pigmentosa

General Information

Clinical trials phase Phase 1
Start date (estimated) 2020-10-05
Clinical feature
Label retinitis pigmentosa
Description A retinal degeneration characterized by the gradual deterioration of the photoreceptors or the retinal pigment epithelium of the retina leading to progressive sight loss.; Xref MGI. OMIM mapping confirmed by DO. [LS].

Administrative Information

ICTRP weblink
Other study identifiers
Name jRCTa050200027
Description Japan Registry of Clinical Trials (jRCT)
Source weblink
Public contact
Public email
First name Shigeki
Last name Yamasaki
Phone +81-78-381-9876
City Kobe
Address freetext 2-1-8 Minatojima-minamimachi, Chuo-ku, Kobe Hyogo, Japan


Which differentiated cell type is used
Label retina
Description The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.; Currently this class encompasses only verteberate AOs but could in theory also include cephalopod - we may want to make a more specific class for vertebrate retina. note that this class excludes ommatidial retinas, as the retina must be part of an eyeball. Use the parent class photoreceptor array / light-sensitive tissue for arthropods


Recruitment Status Recruiting
Estimated number of participants 2
Contact institutions/departments